BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 2086335)

  • 1. [Clinical follow-up studies on the prognostic significance of immunohistochemical estrogen receptor determination of breast cancer].
    Beck T; Finger C; Weikel W; Mitze M; Kreienberg R
    Geburtshilfe Frauenheilkd; 1990 Dec; 50(12):935-40. PubMed ID: 2086335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical detection of hormone receptors in breast carcinomas (ER-ICA, PgR-ICA): prognostic usefulness and comparison with the biochemical radioactive-ligand-binding assay (DCC).
    Beck T; Weikel W; Brumm C; Wilkens C; Pollow K; Knapstein PG
    Gynecol Oncol; 1994 May; 53(2):220-7. PubMed ID: 8188083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Long-term study of the significance of hormone receptors as prognostic factors in breast cancer].
    Merkle E; Seidl I; Bähr I; Tulusan AH; von Maillot K; Sauerbrei KW; Wirtz PM
    Geburtshilfe Frauenheilkd; 1990 Jul; 50(7):528-32. PubMed ID: 2391019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prognostic and therapeutic significance of steroid receptors in invasive breast cancer].
    Wyss P; Rageth JC; Unger C; Hochuli E
    Geburtshilfe Frauenheilkd; 1992 Oct; 52(10):611-6. PubMed ID: 1294437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Re-evaluating adjuvant breast cancer trials: assessing hormone receptor status by immunohistochemical versus extraction assays.
    Regan MM; Viale G; Mastropasqua MG; Maiorano E; Golouh R; Carbone A; Brown B; Suurküla M; Langman G; Mazzucchelli L; Braye S; Grigolato P; Gelber RD; Castiglione-Gertsch M; Price KN; Coates AS; Goldhirsch A; Gusterson B;
    J Natl Cancer Inst; 2006 Nov; 98(21):1571-81. PubMed ID: 17077359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simultaneous immunohistochemical and biochemical hormone receptor assessment in breast cancer provides complementary prognostic information.
    Biesterfeld S; Schröder W; Steinhagen G; Koch R; Veuskens U; Schmitz FJ; Handt S; Böcking A
    Anticancer Res; 1997; 17(6D):4723-9. PubMed ID: 9494596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The prognostic significance of cathepsin D in primary breast cancer].
    Crombach G; Ingenhorst A; Göhring UJ; Scharl A; Schaeffer HJ; Stützer H; Bolte A
    Geburtshilfe Frauenheilkd; 1994 Oct; 54(10):545-51. PubMed ID: 8001750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Quantitative determination with image analysis of immunohistochemically identified steroid hormone receptors in breast carcinoma].
    Mink D; Uhrmacher S; Heiss C; Villena-Heinsen C; Schmidt W
    Geburtshilfe Frauenheilkd; 1995 Jan; 55(1):17-22. PubMed ID: 7705593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Steroid hormone receptors in mammary carcinoma. Immunohistochemical detection and prognostic significance].
    Reiner A; Neumeister B; Reiner G; Jakesz R; Kolb R; Schemper M; Spona J
    Zentralbl Pathol; 1991; 137(3):233-41. PubMed ID: 1657132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunocytochemical localization of estrogen and progesterone receptor and prognosis in human primary breast cancer.
    Reiner A; Neumeister B; Spona J; Reiner G; Schemper M; Jakesz R
    Cancer Res; 1990 Nov; 50(21):7057-61. PubMed ID: 2208173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The prognostic value of cathepsin D concentration in cytosol of primary breast carcinoma].
    Bussen S; Rempen A; Caffier H
    Zentralbl Gynakol; 1995; 117(5):253-9. PubMed ID: 7793167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estrogen receptor beta--an independent prognostic marker in estrogen receptor alpha and progesterone receptor-positive breast cancer?
    Maehle BO; Collett K; Tretli S; Akslen LA; Grotmol T
    APMIS; 2009 Sep; 117(9):644-50. PubMed ID: 19703124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Immunohistochemical detection and prognostic significance of p53 in the primary tumor of breast carcinoma patients].
    Beck T; Weller E; Weikel W; Brumm C; Wilkens C; Knapstein PG
    Geburtshilfe Frauenheilkd; 1995 May; 55(5):252-7. PubMed ID: 7607381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Short-term outcome of primary operated early breast cancer by hormone and HER-2 receptors.
    Brouckaert O; Pintens S; Van Belle V; Van Huffel S; Camerlynck E; Amant F; Leunen K; Smeets A; Berteloot P; Van Limbergen E; Decock J; Hendrickx W; Weltens C; Van den Bogaert W; Vanden Bempt I; Drijkoningen M; Paridaens R; Wildiers H; Vergote I; Christiaens MR; Neven P
    Breast Cancer Res Treat; 2009 May; 115(2):349-58. PubMed ID: 18629635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oestrogen and progesterone receptors in Nigerian breast cancer: relationship to tumour histopathology and survival of patients.
    Ikpatt OF; Ndoma-Egba R
    Cent Afr J Med; 2003; 49(11-12):122-6. PubMed ID: 15301464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biologic and clinical characteristics of breast cancer with single hormone receptor positive phenotype.
    Rakha EA; El-Sayed ME; Green AR; Paish EC; Powe DG; Gee J; Nicholson RI; Lee AH; Robertson JF; Ellis IO
    J Clin Oncol; 2007 Oct; 25(30):4772-8. PubMed ID: 17876012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prognostic differentiation of ovarian carcinomas by immunohistochemical analysis of estrogen receptor expression].
    Kieback DG; Press MF; McCamant SK; Atkinson EN; Möbus VJ; Runnebaum IB; Kreienberg R; Jones LA
    Geburtshilfe Frauenheilkd; 1995 Apr; 55(4):189-94. PubMed ID: 7789706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Local recurrence after mastectomy for breast cancer: analysis of clinicopathological, biological and prognostic characteristics.
    Carreño G; Del Casar JM; Corte MD; González LO; Bongera M; Merino AM; Juan G; Obregón R; Martínez E; Vizoso FJ
    Breast Cancer Res Treat; 2007 Mar; 102(1):61-73. PubMed ID: 16850244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid and prognostically valid quantification of immunohistochemical reactions by immunohistometry of the most positive tumour focus. A prospective follow-up study on breast cancer using antibodies against MIB-1, PCNA, ER, and PR.
    Biesterfeld S; Klüppel D; Koch R; Schneider S; Steinhagen G; Mihalcea AM; Schröder W
    J Pathol; 1998 May; 185(1):25-31. PubMed ID: 9713356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative immunohistochemical assay for hormonal receptors: technical aspects and biological significance.
    Esteban JM; Ahn C; Battifora H; Felder B
    J Cell Biochem Suppl; 1994; 19():138-45. PubMed ID: 7823586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.